1
|
Delialis D, Georgiopoulos G, Sopova K, Kanakakis I, Kontogiannis C, Bampatsias D, Karapanou L, Armeni E, Augoulea A, Spyridopoulos K, Stellos K, Lamprinoudaki I, Stamatelopoulos K. P2541Plasma levels of amyloid beta 1-40 are associated with the rate of progression of carotid subclinical atherosclerosis in postmenopausal women. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
There is increasingly recognized undetected residual cardiovascular (CV) risk in postmenopausal women, suggesting the need for new risk biomarkers in this population. We have previously shown that amyloid-beta (1–40) (Aβ1–40), a proinflammatory and pro-atherosclerotic peptide, is associated with concurrent subclinical cardiovascular disease (CVD) in the general population and with major adverse cardiac events in patients with established cardiac disease. However, the clinical value of Aβ1–40 in menopause or whether this peptide is linked with an increased rate of progression of atherosclerotic disease is unknown.
Purpose
To examine the association of Aβ1–40 levels with the rate of progression of carotid intima-media thickness (IMT) in postmenopausal women.
Methods
In the settings of a Menopause Clinic, postmenopausal women (n=140) without clinically overt CVD or diabetes were consecutively recruited and re-evaluated after a median follow-up period of 24 months. IMT in the carotid arteries was measured by ultrasonography. The average of maximal IMT (mean cIMT) measured at both left and right common carotid, carotid bulb (cb)and internal carotid (ic) artery were used as the main end-point of the analysis. Aβ1–40 was measured in plasma samples at baseline and follow up. Fasting insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR).
Results
Women with increased plasma levels Aβ1–40 in the highest tertile presented the highest probability to have increased mean cIMT (adjusted OR=2.97, 95% CI 1.18–7.52, p=0.021) independently of age, smoke, hypertension, and hyperlipidemia. After adjustment for HOMA-IR, this association remained significant. Similarly, Aβ1–40 levels were associated with increased mean cb and icIMT (adjusted OR=3.34 for highest versus lower tertile, 95% CI 1.27–8.81, p=0.015). Mean cIMT significantly increased across the follow up period (0.73mm (0.065–0.08) to 0.77mm (0.07–0.089), median increase rate per year 0.024mm, p<0.001). By multi-level linear mixed model analysis, changes in Aβ1–40 levels were associated with increased rate of progression of mean cIMT (4.1% increase per 1-SD increase, p<0.001) after adjustment for differences in follow-up duration and age, hypertension, hyperlipidemia, and smoking. When repeated measurements of HOMA-IR were also considered, this association did not materially change (p=0.021). Similarly, longitudinal changes in Aβ1–40 correlated with the progression of mean cb and icIMT (3.9% increase per 1-SD increase, p=0.001), independently of time to re-evaluation and cardiovascular risk factors.
Conclusion
Aβ1–40 is an independent predictor of the rate of progression of subclinical carotid atherosclerosis in menopausal women. This finding supports the clinical value of Aβ1–40 in menopause and warrants further investigation for its prognostic role in this population.
Collapse
Affiliation(s)
- D Delialis
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - G Georgiopoulos
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - K Sopova
- Wolfgang Goethe University, Frankfurt am Main, Germany
| | - I Kanakakis
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - C Kontogiannis
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - D Bampatsias
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - L Karapanou
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| | - E Armeni
- Aretaieio Hospital, Department of Obstetrics and Gynecology, Athens, Greece
| | - A Augoulea
- Aretaieio Hospital, Department of Obstetrics and Gynecology, Athens, Greece
| | | | - K Stellos
- Newcastle University, Newcastle upon Tyne, United Kingdom
| | - I Lamprinoudaki
- Aretaieio Hospital, Department of Obstetrics and Gynecology, Athens, Greece
| | - K Stamatelopoulos
- Alexandra University Hospital, Department of Clinical Therapeutics, Athens, Greece
| |
Collapse
|
2
|
Georgiopoulos G, Stakos D, Bakogiannis K, Kontogiannis C, Augoulea A, Armeni E, Laina A, Mareti A, Petropoulos I, Kanakakis I, Karapanou L, Bampatsias D, Lambrinoudaki I, Papamichael C, Stamatelopoulos K. P1565Abdominal tissue echogenicity in postmenopausal women. A novel marker of morbid obesity? Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G Georgiopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Stakos
- Democritus University of Thrace, Cardiology Department, Alexandroupolis, Greece
| | - K Bakogiannis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - C Kontogiannis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - A Augoulea
- Aretaieio Hospital, 2nd Department of Obstetrics and Gynecology, Athens, Greece
| | - E Armeni
- Aretaieio Hospital, 2nd Department of Obstetrics and Gynecology, Athens, Greece
| | - A Laina
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, Athens, Greece
| | - A Mareti
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Petropoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Kanakakis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - L Karapanou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Bampatsias
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Lambrinoudaki
- Aretaieio Hospital, 2nd Department of Obstetrics and Gynecology, Athens, Greece
| | - C Papamichael
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - K Stamatelopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| |
Collapse
|
3
|
Georgiopoulos G, Lavda M, Papaioannou T, Laina A, Georgiou S, Mareti A, Mavroeidis I, Samouilidou E, Bampatsias D, Karapanou L, Kanakakis I, Makris N, Papamichael C, Tousoulis D, Stamatelopoulos K. P1554A non-invasive vascular multi-marker approach for the detection of coronary artery disease and future adverse events in high cardiovascular risk patients. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G Georgiopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - M Lavda
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - T Papaioannou
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - A Laina
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - S Georgiou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - A Mareti
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Mavroeidis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - E Samouilidou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Bampatsias
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - L Karapanou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Kanakakis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - N Makris
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - C Papamichael
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Tousoulis
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - K Stamatelopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| |
Collapse
|
4
|
Georgiopoulos G, Laina A, Alexopoulou A, Mareti A, Bampatsias D, Karapanou L, Pouriki S, Kanakakis I, Vasilieva L, Mani I, Koutli E, Mavroeidis I, Papamichael C, Dourakis SP, Stamatelopoulos K. P5428Deterioration of vascular and hemodynamic markers during and after pegylated interferon and ribavirin treatment for chronic hepatitis C. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5428] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- G Georgiopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - A Laina
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - A Alexopoulou
- Hippokration General Hospital, 2nd Department of Internal Medicine and Research Laboratory, National and Kapodistrian University, Athens, Greece
| | - A Mareti
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Bampatsias
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - L Karapanou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - S Pouriki
- Hippokration General Hospital, 2nd Department of Internal Medicine and Research Laboratory, National and Kapodistrian University, Athens, Greece
| | - I Kanakakis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - L Vasilieva
- Hippokration General Hospital, 2nd Department of Internal Medicine and Research Laboratory, National and Kapodistrian University, Athens, Greece
| | - I Mani
- Hippokration General Hospital, 2nd Department of Internal Medicine and Research Laboratory, National and Kapodistrian University, Athens, Greece
| | - E Koutli
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Mavroeidis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - C Papamichael
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - S P Dourakis
- Hippokration General Hospital, 2nd Department of Internal Medicine and Research Laboratory, National and Kapodistrian University, Athens, Greece
| | - K Stamatelopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| |
Collapse
|
5
|
Laina A, Papaioannou T, Georgiopoulos G, Magkas N, Mareti A, Mavroeidis I, Georgiou S, Samouilidou E, Karapanou L, Bampatsias D, Makris N, Papamichael C, Tousoulis D, Kanakakis I, Stamatelopoulos K. P6292Age-dependent associations of carotid-to-femoral pulse wave velocity with coronary artery disease, cardiovascular risk and myocardial aging in high-risk patients. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Laina
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - T Papaioannou
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - G Georgiopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - N Magkas
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - A Mareti
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - I Mavroeidis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - S Georgiou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - E Samouilidou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - L Karapanou
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Bampatsias
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - N Makris
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - C Papamichael
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - D Tousoulis
- Hippokration General Hospital, First Department of Cardiology, National and Kapodistrian University, Athens, Greece
| | - I Kanakakis
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| | - K Stamatelopoulos
- Alexandra University Hospital, Vascular Laboratory, Department of Clinical Therapeutics, National and Kapodistrian University, Athens, Greece
| |
Collapse
|